Abiopharma

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies, which management generally defines as U.S. based companies with revenues between $10 million and $150 million. The companys investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity-related investments.

Additional info from NASDAQ:
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies, which management generally defines as U.S. based companies with revenues between $10 million and $150 million. The companys investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity-related investments.